Employment AgreementEmployment Agreement • March 16th, 2023 • Sight Sciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledMarch 16th, 2023 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 7, 2021, is made by and between Sight Sciences, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Jeremy Hayden (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
Employment AgreementEmployment Agreement • July 12th, 2021 • Rapid Micro Biosystems, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledJuly 12th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 8, 2021, is made by and between Rapid Micro Biosystems, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Sean Wirtjes (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
Employment AgreementEmployment Agreement • July 12th, 2021 • Rapid Micro Biosystems, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledJuly 12th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 8, 2021, is made by and between Rapid Micro Biosystems, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Jonathan Paris (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
Employment AgreementEmployment Agreement • July 12th, 2021 • Rapid Micro Biosystems, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledJuly 12th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 8, 2021, is made by and between Rapid Micro Biosystems, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Robert Spignesi (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
Employment AgreementEmployment Agreement • July 12th, 2021 • Rapid Micro Biosystems, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledJuly 12th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 8, 2021, is made by and between Rapid Micro Biosystems, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and John Wilson (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
Employment AgreementEmployment Agreement • July 12th, 2021 • Rapid Micro Biosystems, Inc. • Laboratory analytical instruments • Massachusetts
Contract Type FiledJuly 12th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of July 8, 2021, is made by and between Rapid Micro Biosystems, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Victoria Vezina (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).